Hims & Hers holder plans $467K stock sale in 2026

Hims & Hers Health, Inc. (HIMS) is the issuer in a planned secondary sale by stockholder Deborah M. Autor under Rule 144.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) is the issuer in a planned secondary sale by stockholder Deborah M. Autor under Rule 144. A notice was filed for the potential sale of 16,773 Class A shares through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $467,128.05 for these shares and total Class A shares outstanding of 224,935,790. The shares relate to restricted stock vesting designated as compensation, with a noted proposed sale date of August 18, 2026 on the NYSE.

Key Figures

Shares to be sold: 16,773 shares Aggregate market value: $467,128.05 Shares outstanding: 224,935,790 shares +2 more

5 metrics

Shares to be sold 16,773 shares Class A common stock covered by the Rule 144 notice

Aggregate market value $467,128.05 Reported value of 16,773 Class A shares in the planned sale

Shares outstanding 224,935,790 shares Total Hims & Hers Class A shares outstanding referenced in the notice

Proposed sale date 08/18/2026 Date associated with the planned Rule 144 sale on NYSE

Vesting date 08/15/2026 Date tied to restricted stock vesting for the compensation shares

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Class A | 08/15/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Deborah M. Autor"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for HIMS shareholders?

The filing reports a planned secondary sale of Hims & Hers Health, Inc. shares by a stockholder under Rule 144. It does not register new shares or raise capital for the company; it simply discloses a potential resale of existing shares.

How many Hims & Hers (HIMS) shares are covered by this Form 144?

The notice covers a potential sale of 16,773 Class A shares of Hims & Hers Health, Inc. It is a disclosure of intent to sell these already-issued shares rather than an offering of new equity by the company.

What is the market value of the HIMS shares in this planned Rule 144 sale?

The filing lists an aggregate market value of $467,128.05 for the 16,773 Class A shares. This value reflects the reference price used in the notice and provides scale for the size of the potential shareholder sale.

How many Hims & Hers (HIMS) Class A shares are outstanding according to this filing?

The notice states that 224,935,790 Class A shares of Hims & Hers Health, Inc. are outstanding. This figure gives context for the size of the potential 16,773-share sale relative to the company’s total Class A equity base.

Who is selling HIMS shares and through which broker?

The potential sale is for the account of Deborah M. Autor, with Fidelity Brokerage Services LLC listed in connection with the Class A shares. The Form 144 is signed by a Fidelity representative acting as attorney-in-fact for her.

What is the source of the HIMS shares to be sold under this Form 144?

The filing states the Class A shares are tied to restricted stock vesting classified as compensation

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 10:37 AM EDT Accepted by SEC EDGAR 08/18/2026 - 10:37 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001884671
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Autor Deborah M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16773	467128.05	224935790	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	08/15/2026	Restricted Stock Vesting	Issuer			16773	08/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Deborah M. Autor
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)